These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8377367)

  • 21. New positive inotropic agents.
    Jafri SM; Bristol JA
    Henry Ford Hosp Med J; 1986; 34(3):188-92. PubMed ID: 3542907
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical management of heart failure secondary to coronary artery disease.
    Challapalli S; Bonow RO; Gheorghiade M
    Coron Artery Dis; 1998; 9(10):659-74. PubMed ID: 9894618
    [No Abstract]   [Full Text] [Related]  

  • 23. [Stimulating and hypobiotic therapy in cardiogenic shock].
    Bobrov VA; Shved NI; Sherman DM
    Lik Sprava; 1994; (5-6):7-12. PubMed ID: 7831916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of new drugs for chronic congestive heart failure and stable angina--a clinicians's view.
    Permanyer-Miralda G
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():39-40. PubMed ID: 9003576
    [No Abstract]   [Full Text] [Related]  

  • 26. [Positive inotropic substances. Possible use in heart failure in the aged].
    Michel D
    Fortschr Med; 1991 Aug; 109(25):496-9. PubMed ID: 1937336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 28. Inotropic therapy for heart failure--an unfulfilled promise.
    Curfman GD
    N Engl J Med; 1991 Nov; 325(21):1509-10. PubMed ID: 1944430
    [No Abstract]   [Full Text] [Related]  

  • 29. Is modulation of sodium-calcium exchange a therapeutic option in heart failure?
    Hasenfuss G; Schillinger W
    Circ Res; 2004 Aug; 95(3):225-7. PubMed ID: 15297383
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs used in heart disease. 1. Pharmacology--1.
    Landowski R; Shulman R; Davies R
    Nurs Times; 2002 Apr 30-May 6; 98(18):43-6. PubMed ID: 12035447
    [No Abstract]   [Full Text] [Related]  

  • 31. Is inotropic therapy for heart failure an unfulfilled promise?
    Dorigo P
    Pharmacol Res; 1992 Sep; 26(2):103-7. PubMed ID: 1409252
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamic effects of calcium-sensitizing agents.
    Vegh A; Papp JG; Udvary E; Kaszala K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel pharmacological treatments for heart failure.
    Tang WH; Francis GS
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1791-801. PubMed ID: 14585055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Searching for the ideal inotropic agent to rescue a failing heart.
    Howlett SE
    Cardiovasc Res; 2011 Aug; 91(3):371-2. PubMed ID: 21652598
    [No Abstract]   [Full Text] [Related]  

  • 35. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 36. [The treatment of chronic cardiac decompensation].
    van Zanten RA; Laird-Meeter K
    Ned Tijdschr Geneeskd; 1987 Apr; 131(15):615-8. PubMed ID: 3574530
    [No Abstract]   [Full Text] [Related]  

  • 37. Through the looking glass: a positive inotropic drug and ischemic preconditioning.
    Vander Heide RS; Marsh JD
    Circulation; 1997 Apr; 95(8):1989-91. PubMed ID: 9133503
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of ischemic and nonischemic heart failure. Current status and prospects].
    Weil J; Riegger G
    Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003
    [No Abstract]   [Full Text] [Related]  

  • 40. [[Meldonium in treatment of patients with myocardial infarction].
    Nechaeva GI; Potashov DA; Zheltikova EN
    Kardiologiia; 2014; 54(9):93-6. PubMed ID: 25702409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.